Researchers will determine if genetic factors and co-administered drugs influence the clinical effectiveness of tramadol, a commonly used pain-relief drug in dogs.

Researchers will investigate the role of a small protein released in response to inflammation as a potential new therapy target to control itch and inflammation in dogs with chronic, relapsing allergic skin disease.

Researchers will investigate the effectiveness of an oral vitamin D supplement to improve vitamin D levels in dogs, and explore its potential benefit as an adjunct therapy in dogs with cancer.

Researchers will search for genetic mutations associated with mitral valve disease, a common heart condition in small breed dogs, to improve disease management and prevention.

Researchers will evaluate the efficacy of a vaccine for visceral leishmaniasis, a parasitic disease, in United States foxhounds.

Researchers are studying a group of 80 dogs with osteosarcoma to generate comparison data for ongoing and future studies of new chemotherapeutic agents.

Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.

This grant supports the advanced training of two aspiring veterinary pathologists who will assist with the analysis of tissue samples collected from dogs enrolled in Morris Animal Foundation's Golden Retriever Lifetime Study.

Researchers will investigate how equine muscle cells regulate calcium movement, and examine its role in equine muscle diseases.

Researchers will evaluate the ability of a unique population of cells called interzone cells to produce new cartilage in horses with joint damage.